Bettina Langhans

Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Interferon-gamma-inducible protein-10 is associated to increased primary bile acids and fibrosis in primary sclerosing cholangitis.

Interferon-gamma-inducible protein-10 is associated to increased primary bile acids and fibrosis in primary sclerosing cholangitis.

Journal: The Journal of steroid biochemistry and molecular biology

Published: April 23, 2026

The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids.

The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids.

Journal: Biomedicines

Published: March 13, 2025

A Common UDP-Glucuronosyltransferase (UGT)1A Haplotype Is Associated With Accelerated Aging in Humanized Transgenic Mice.

A Common UDP-Glucuronosyltransferase (UGT)1A Haplotype Is Associated With Accelerated Aging in Humanized Transgenic Mice.

Journal: Oxidative medicine and cellular longevity

Published: November 06, 2024

Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma.

Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma.

Journal: Human pathology

Published: July 25, 2024

Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype.

Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype.

Journal: BMC gastroenterology

Published: April 02, 2024

STAT activation in regulatory CD4+ T cells of patients with primary sclerosing cholangitis.

STAT activation in regulatory CD4+ T cells of patients with primary sclerosing cholangitis.

Journal: Immunity, inflammation and disease

Published: December 20, 2023

Role of PAR1 -506 deletion/insertion polymorphism in primary sclerosing cholangitis.

Role of PAR1 -506 deletion/insertion polymorphism in primary sclerosing cholangitis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 11, 2023

Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.

Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.

Journal: Hepatology communications

Published: October 17, 2023

Torque Teno Virus Load Is Associated With Centers for Disease Control and Prevention Stage and CD4+ Cell Count in People Living With Human Immunodeficiency Virus but Seems Unrelated to AIDS-Defining Events and Human Pegivirus Load.

Torque Teno Virus Load Is Associated With Centers for Disease Control and Prevention Stage and CD4+ Cell Count in People Living With Human Immunodeficiency Virus but Seems Unrelated to AIDS-Defining Events and Human Pegivirus Load.

Journal: The Journal of infectious diseases

Published: October 09, 2023

IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing Cholangitis.

IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing Cholangitis.

Journal: Clinical and translational gastroenterology

Published: November 07, 2022

Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients.

Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients.

Journal: International journal of molecular sciences

Published: November 02, 2022

High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.

High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.

Journal: JHEP reports : innovation in hepatology

Published: August 15, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026